MFSD2A and Cognitive impairment: The recombinant AAV (overexpressing Mfsd2a) upregulated the expression of Mfsd2a protein in the hippocampus of CCH rats, inhibited the active vesicle transcytosis, and ameliorated cognitive impairment of CCH rats.